<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<oembed>
  <author_name>okumi</author_name>
  <author_url>https://blog.hatena.ne.jp/okumi/</author_url>
  <blog_title>リプロな日記</blog_title>
  <blog_url>https://okumi.hatenablog.com/</blog_url>
  <categories>
  </categories>
  <description>日本支社による中絶薬MEFEEGOの承認申請 LINEPHARMA INTERNATIONAL FILES FOR MANUFACTURING, MARKETING APPROVAL OF THE ABORTION PILL IN JAPANLONDON and TOKYO, Dec. 22, 2021 /CNW/ - Linepharma International Ltd., a global leader in medical abortion, announced today that its subsidiary Linepharma KK has applied for manuf…</description>
  <height>190</height>
  <html>&lt;iframe src=&quot;https://hatenablog-parts.com/embed?url=https%3A%2F%2Fokumi.hatenablog.com%2Fentry%2F2021%2F12%2F21%2F000000&quot; title=&quot;Linepharma Internationalの発表 - リプロな日記&quot; class=&quot;embed-card embed-blogcard&quot; scrolling=&quot;no&quot; frameborder=&quot;0&quot; style=&quot;display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;&quot;&gt;&lt;/iframe&gt;</html>
  <image_url></image_url>
  <provider_name>Hatena Blog</provider_name>
  <provider_url>https://hatena.blog</provider_url>
  <published>2021-12-21 00:00:00</published>
  <title>Linepharma Internationalの発表</title>
  <type>rich</type>
  <url>https://okumi.hatenablog.com/entry/2021/12/21/000000</url>
  <version>1.0</version>
  <width>100%</width>
</oembed>
